Strauss W E, Egan T, McIntyre K M, Parisi A F
Clin Cardiol. 1985 Jun;8(6):363-6. doi: 10.1002/clc.4960080612.
Although congestive heart failure has been reported with the combination of a beta blocker and either verapamil or nifedipine, it has not previously been reported for combination therapy that includes diltiazem. The following case documents the occurrence of clinical congestive failure in a patient with baseline left ventricular dysfunction and severe angina pectoris. Although the patients had tolerated propranolol therapy for years without difficulty, and high-dose diltiazem monotherapy with an excellent clinical response, the combination of diltiazem and propranolol resulted in the development of congestive heart failure. Thus, although generally well tolerated, given the suitable scenario of reduced left ventricular function, the combination of diltiazem and a beta blocker may adversely affect left ventricular performance.
虽然已有报告称β受体阻滞剂与维拉帕米或硝苯地平联合使用会导致充血性心力衰竭,但此前尚未有关于包括地尔硫䓬在内的联合治疗导致该情况的报告。以下病例记录了一名基线存在左心室功能障碍和严重心绞痛的患者发生临床充血性心力衰竭的情况。尽管该患者多年来一直耐受普萘洛尔治疗且无困难,并且单独使用高剂量地尔硫䓬治疗时临床反应良好,但地尔硫䓬与普萘洛尔联合使用却导致了充血性心力衰竭的发生。因此,尽管通常耐受性良好,但在左心室功能降低的合适情况下,地尔硫䓬与β受体阻滞剂联合使用可能会对左心室功能产生不利影响。